Home › Funds › JNE Partners LLP › BIO
JNE Partners LLP position in BIO
BIO RAD LABS INC · Industrials
JNE Partners LLP reported holding 84,817 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$32.0M, representing 13.27% of its reported portfolio and ranking #4 among its reported holdings. JNE Partners LLP has disclosed BIO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How JNE Partners LLP's BIO position evolved
JNE Partners LLP first disclosed a stake in BIO in Q2 2025 at 92,100 shares (US$22.2M). The position peaked in Q3 2026 at 84,817 shares, worth US$32.0M. Across 6 filings, JNE Partners LLP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 84,817 shares valued at US$32.0M — a reduction of -3,694 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 92.10K | $22.23M | New |
| Q3 2025 | 92.10K | $25.82M | Hold |
| Q4 2025 | 92.10K | $27.91M | Hold |
| Q1 2026 | 92.10K | $25.67M | Hold |
| Q2 2026 | 88.51K | $25.99M | Reduce |
| Q3 2026 | 84.82K | $32.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIO and 13F data
BIO (BIO RAD LABS INC) is a Industrials company. 28 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIO
- First Eagle Investment Management 2.46M sh · $927.50M · Q3 2026
- ARIEL INVESTMENTS, LLC 789.34K sh · $298.14M · Q3 2026
- EARNEST PARTNERS LLC 567.82K sh · $214.47M · Q3 2026
- First Pacific Advisors, LP 269.08K sh · $101.63M · Q3 2026
- NOMURA HOLDINGS INC 328.90K sh · $96.57M · Q2 2026
More on JNE Partners LLP
FAQ
How long has JNE Partners LLP held BIO?
JNE Partners LLP has disclosed BIO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is JNE Partners LLP's current position in BIO?
As of Q3 2026, JNE Partners LLP holds 84.82K shares of BIO (BIO RAD LABS INC), valued at $32.04M, representing 13.27% of its reported portfolio and ranking #4.
Has JNE Partners LLP been buying or selling BIO?
In the latest 13F filing (Q3 2026), JNE Partners LLP reduced its position in BIO. The position peaked in Q3 2026 at 84.82K shares.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.